Supplementary Table – First-line Osimertinib in EGFR mutation-positive non-small cell lung cancer patients with poor performance status
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://figshare.com/articles/dataset/Supplementary_Table_First-line_Osimertinib_in_EGFR_mutation-positive_non-small_cell_lung_cancer_patients_with_poor_performance_status/16988269
下载链接
链接失效反馈官方服务：
资源简介：
Supplementary Table
1. First-line Osimertinib in EGFR
mutation-positive non-small cell lung cancer patients with poor performance
status
The reasons for
dose reduction
创建时间：
2021-11-11
